摘要
血管内皮生长因子(VEGF)既是一种多能性的生长因子,又是一种通透因子,在正常肺组织中大量表达,通过血管内皮生长因子受体(VEGFR)发挥其生理作用,具有促有丝分裂、血管生成和内皮细胞存活,增加血管通透性等作用,在急性肺损伤的发生、发展及转归中是一把双刃剑,其作用日益引起人们的重视。通过对VEGF在ALI/ARDS不同阶段中的作用的研究,有望为ALI/ARDS的药物治疗提供理论依据。
Vascular endothelial growth factor( VEGF) as an angiogenic and chemotactic peptide, is a pluripotential endothelial cell growth and permeability factor, abundantly expressed in normal lung tissue, especially in alveolar and bronchial epithelium. It can induce mitochysis, angiogenesis, endothelial cell survival and enhance vascular permeability. It plays different roles in the different development stage of ALI/ARDS, which may provide a new clinical therapy for ALI/ARDS.
出处
《中国急救医学》
CAS
CSCD
北大核心
2008年第12期1135-1138,共4页
Chinese Journal of Critical Care Medicine
关键词
血管内皮生长因子
肺损伤
Vascular endothelial growth factor( VEGF)
Acute lung injury